neostigmine has been researched along with Thyrotoxicosis in 2 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Thyrotoxicosis: A hypermetabolic syndrome caused by excess THYROID HORMONES which may come from endogenous or exogenous sources. The endogenous source of hormone may be thyroid HYPERPLASIA; THYROID NEOPLASMS; or hormone-producing extrathyroidal tissue. Thyrotoxicosis is characterized by NERVOUSNESS; TACHYCARDIA; FATIGUE; WEIGHT LOSS; heat intolerance; and excessive SWEATING.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
IRONSIDE, R | 1 |
Shrivastava, MP | 1 |
Datta, TK | 1 |
Madiajagne, R | 1 |
2 other studies available for neostigmine and Thyrotoxicosis
Article | Year |
---|---|
Progressive exophthalmoplegia with muscular atrophy, myasthenia, and thyrotoxicosis.
Topics: Humans; Hyperthyroidism; Muscles; Muscular Atrophy; Neostigmine; Oculomotor Muscles; Thyrotoxicosis | 1951 |
Thyrotoxicosis with myasthenia--an unusual association.
Topics: Adult; Blepharoptosis; Carbimazole; Female; Humans; Myasthenia Gravis; Neostigmine; Prednisolone; Th | 1991 |